Evolva Holding en liquidation Ltd - Company Profile
Powered by
All the data and insights you need on Evolva Holding en liquidation Ltd in one report.
- Save hours of research time and resources with
our up-to-date Evolva Holding en liquidation Ltd Strategy Report
- Understand Evolva Holding en liquidation Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Evolva Holding en liquidation Ltd (Evolva), formerly Evolva Holding SA, is a biotechnology company that develops, produces, and supplies high-purity nature-based ready-to-formulate ingredients with applications in the flavor, dietary supplements, cosmetics, and pharmaceutical sectors. The company's product portfolio comprises L-Arabinose, Stevia, Resveratrol, Nootkatone, NootkaSHIELD and Valencene. Evolva’s products find application in diverse areas, including food, nutrition, pharmaceuticals, pest control, and others. The company also provides health ingredients and scientific and technical support to its customer base. Evolva markets its products under the Evolva, Veri-te, L-Arabinose, and EverSweet brand names. It has a business presence in the US, the UK, Switzerland, Denmark, and India. Evolva is headquartered in Reinach, Switzerland.
Products and Services
Products | Brands |
---|---|
Resveratrol | Evolva |
L-Arabinose | Veri-te |
Valencene | L-Arabinose |
XYZ | XYZ |
XYZ | XYZ |
XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | Contracts/Agreements | In November, the company entered into an agreement with Breko for the exclusive distribution of Veri-teTM Resveratrol in Germany, Austria, Thailand and Vietnam. |
2023 | Contracts/Agreements | In September, the company entered into an agreement with LEHVOSS for distribution of Veri teTM resveratrol in over a dozen European countries. |
2023 | Contracts/Agreements | In June, the company entered into an agreement with Nice & Green to secure financing. |
Competitor Comparison
Key Parameters | Evolva Holding en liquidation Ltd | Ingredion Inc | Amyris Inc | Basilea Pharmaceutica Ltd | PureCircle Ltd |
---|---|---|---|---|---|
Headquarters | Switzerland | United States of America | United States of America | Switzerland | Malaysia |
City | Reinach | Westchester | Emeryville | Allschwil | Kuala Lumpur |
State/Province | - | Illinois | California | - | Kuala Lumpur (Federal Territory of) |
No. of Employees | 49 | 11,600 | 1,598 | 147 | 1,100 |
Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Beat In-Albon | Vice Chairman | Executive Board | 2023 | 71 |
Christian Wichert | Chief Executive Officer | Senior Management | 2022 | 49 |
Carsten Däweritz | Chief Financial Officer | Senior Management | 2021 | 50 |
Gerhard Lobmaier | Chief Operating Officer | Senior Management | 2021 | 54 |
Anne De Vos | Chief Commercial Officer | Senior Management | 2022 | 59 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer